MedTrace Logo

Aspirin, Heparin and Miscarriage

NCT01917799 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2013-08-07

No results posted yet for this study

Summary

Efficacy of low dose aspirin (LDA) versus LDA plus low-molecular-weight-heparin (LMWH) in patients with a history of recurrent miscarriages.

Conditions

  • Pregnancy
  • Miscarriage

Interventions

DRUG

Aspirin

75mg tab of LDA once daily for 7 months

DRUG

Heparin

0.4 mL/day of the Enoxaparin

Sponsors & Collaborators

  • University of Khartoum

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
48 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2013-11-30
Completion
2013-12-31

Countries

  • Libya

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01917799 on ClinicalTrials.gov